Federal healthcare reform has prompted an increase in the overall number of patients seeking care at a time when clinicians are in short supply. Retail clinics have risen to the occasion, promising quality care faster and cheaper than traditional healthcare access points.

So alluring is the value proposition of easily accessible, affordable care that some of the nation’s most powerful players are partnering with retail clinics to improve medication adherence and drive down overall costs. This executive briefing explores retail clinics’ expanding influence in the provider, payer and patient spheres, challenging conventional roles and begging the question: What’s next?

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now